ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature

ClinicalTrials.gov ID: NCT01248416

Public ClinicalTrials.gov record NCT01248416. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 8:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Controlled Trial Of The Use Of Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature

Study identification

NCT ID
NCT01248416
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Nemours Children's Clinic
Other
Enrollment
76 participants

Conditions and interventions

Interventions

  • Aromatase Inhibitor Drug
  • Aromatase Inhibitor and Growth Hormone Drug
  • Growth Hormone Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 18 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2010
Primary completion
Aug 31, 2016
Completion
Aug 31, 2016
Last update posted
Aug 6, 2018

2010 – 2016

United States locations

U.S. sites
3
U.S. states
2
U.S. cities
3
Facility City State ZIP Site status
Nemours Children's Clinic Jacksonville Florida 32207
Nemours Children's Clinic Orlando Florida 32801
Nemours Children's Clinic- Jefferson Philadelphia Pennsylvania 19107

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01248416, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 6, 2018 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01248416 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →